Patents-Review.com
🔗 Permalink
Inventor profile of:

Bernd CLEMENT

City:

Kiel

Country:

Germany

Published Applications:

22

Last publication date:

2023-08-31

Top Assignees for applications by Bernd CLEMENT

The entities that hold a legal rights for patent applications filed by inventor CLEMENT Bernd:

Recent patent applications by CLEMENT Bernd

Bernd CLEMENT from Kiel, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-08-31
US20230270709A1
Human necessities

ANTIVIRAL PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION

 #2 | 2019-09-26
US20190292184A1
Chemistry; metallurgy

Pyrido-phenanthroline derivatives, production and use thereof as medicaments

 #3 | 2015-10-01
US20150272910A1
Human necessities

Antibacterial and antifungal biphenylyl compounds

 #4 | 2015-04-23
US20150111965A1
Human necessities

Orally bioavailable pentamidine prodrugs for the treatment of diseases

 #5 | 2015-04-09
US20150099774A1
Chemistry; metallurgy

Pyrido [3,4-C] [1,9] phenanthroline and 11, 12 dihydropyrido [3,4-C] [1,9] phenanthroline derivatives and the use thereof, particularly for treating cancer

 #6 | 2014-11-27
US20140350293A1
Chemistry; metallurgy

Method for producing prodrug from amidoxime and N-hydroxyguanidine carboxylic acid esters

 #7 | 2014-10-30
US20140323763A1
Chemistry; metallurgy

ANTIBACTERIAL AND ANTIFUNGAL SUBSTANCES BIPHENYLYL COMPOUNDS

 #8 | 2014-09-25
US20140288312A1
Chemistry; metallurgy

Compounds for the treatment of influenza

 #9 | 2014-03-06
US20140066648A1
Chemistry; metallurgy

AMINO ACID DERIVATIVES USED AS PHARMACEUTICAL SUBSTANCES

 #10 | 2013-04-04
US20130085180A1
Human necessities

ORAL BIOAVAILABLE PENTAMIDIN PRODRUGS FOR TREATMENT OF DISEASES

 #11 | 2013-01-31
US20130030023A1
Chemistry; metallurgy

Orally bioavailable dabigatran prodrugs for the treatment of diseases

 #12 | 2012-05-17
US20120123111A1
Human necessities

N-hydroxy-L-arginine derivatives for the treatment of diseases

 #13 | 2012-03-29
US20120077876A1
Chemistry; metallurgy

Method For Improved Bioactivation Of Pharmaceuticals

 #14 | 2011-12-01
US20110294878A1
Human necessities

Inhibitors of dimethylarginine dimethylaminohydrolase

 #15 | 2011-02-03
US20110028756A1
Chemistry; metallurgy

USE OF AMIDOXIME CARBOXYLIC ACID ESTERS AND N-HYDROXYGUANIDINE CARBOXYLIC ACID ESTERS FOR PRODUCING PRODRUGS

 #16 | 2011-01-27
US20110021835A1
Chemistry; metallurgy

Amino acid derivatives used as pharmaceutical substances

 #17 | 2010-09-16
US20100234641A1
Human necessities

Basic acetophenones as inhibitors of NO-synthases

 #18 | 2010-03-18
US20100068272A1
Chemistry; metallurgy

HYDROXYAMIDINE AND HYDROXYGUANIDINE COMPOUNDS AS UROKINASE INHIBITORS

 #19 | 2009-10-29
US20090270440A1
Human necessities

BIOAVAILABILITY OF ACTIVE SUBSTANCES HAVING AN AMIDINE FUNCTION IN MEDICAMENTS

 #20 | 2008-10-23
US20080261998A1
Chemistry; metallurgy

Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors

 #21 | 2006-06-29
US20060142305A1
Chemistry; metallurgy

Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors

 #22 | 2006-04-20
US20060084664A1
Chemistry; metallurgy

Substituted pyrido(1,2-a)pyrimidines and their use as NOS inhibitors
InventorID:

68648 ⎘